A common outcome of all types of infection, sepsis can be debilitating and even deadly.
New research into using vitamin C therapy may lead to a drastic reduction in mortality rates, better outcomes for survivors and help ease the burden the condition places on hospitals.
In a study led by Virginia Commonwealth University and published in the Journal of the American Medical Association, researchers conducted a randomised, placebo-controlled, multicentre trial of intravenous vitamin C therapy for sepsis patients.
The results indicate a 16% reduction in mortality in the vitamin C group compared to the placebo group at day 28 of the trial. They also spent an average of three fewer days in the ICU at day 28, and a week less in hospital at day 60.
Further research is needed to confirm these results, but the researchers hope that these encouraging early indications will result in a larger and more definitive trial.
>> Read the original article here
Source: Medical Xpress